Categories Consumer, Health Care, Markets

Johnson & Johnson dips on revenue decline in India

Johnson & Johnson (JNJ) shares fell 1% on Thursday after the company reported a 3% sales dip in India in the year ending March 2018. According to a regulatory filing with the Corporate Affairs Ministry of India, total sales fell to Rs 58.28 billion ($829 million) during this period, primarily hurt by weakness in the medical devices segment.

Revenue from the medical devices segment fell 7% in 2018 after the Asian country imposed strict measures to cap the pricing of medical devices. Meanwhile, sales at the consumer segment, which is quite popular in India, fell marginally to Rs 3,092 crore, driven by the negative publicity surrounding its baby talc products.

Johnson & Johnson talc cases
Image: Wikimedia Commons

Reuters had recently reported that the  New Brunswick, New Jersey-based company knew about the presence of carcinogenic components in its talc products as early as 1971. The report had sent the US pharma giant’s shares plunging.

It may be noted that Johnson & Johnson’s consumer segment accounts for a lion’s share of the baby products market in India.

JNJ stock has declined 9% in the past year.

Johnson & Johnson will spend more time in court in 2019

Meanwhile, the filings show that after-tax gains improved 18% to $98 million during fiscal 2018 in India, including gains from forex transactions.

In 2019, the pharma giant awaits trial in over 11,700 claims. Johnson’s continue to strongly defend its talc-based products against the verdicts it has lost, but it faces an uphill task of restoring brand loyalty. Johnson’s has about $16 billion of funds allocated for any possible payouts.


We’re on Flipboard! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

Does Unity Software (U) stock has more room to run?

Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a

PepsiCo (PEP): Steady snacking habits amid pandemic drive strong quarter for beverage giant

PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the

Does the virus-driven boom make Electronic Arts (EA) a good investment?

With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,

Leave a Reply

Your email address will not be published. Required fields are marked *

Add Comment

Viewing Highlight